| Identification | Back Directory | [Name]
1,5-Naphthyridine-2-carbonitrile, 8-[(2S,5R)-4-[bis(4-chlorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-5,6-dihydro-5-methyl-6-oxo- | [CAS]
2407892-34-4 | [Synonyms]
DGK-IN-1
8-((2S,5R)-4-(bis(4-chlorophenyl)methyl)-2,5-dimethylpiperazin-1-yl)-5-methyl-6-oxo-5,6-dihydro-1,5-naphthyridine-2-carbonitrile
1,5-Naphthyridine-2-carbonitrile, 8-[(2S,5R)-4-[bis(4-chlorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-5,6-dihydro-5-methyl-6-oxo- | [Molecular Formula]
C29H27Cl2N5O | [MOL File]
2407892-34-4.mol | [Molecular Weight]
532.46 |
| Chemical Properties | Back Directory | [Boiling point ]
660.2±55.0 °C(Predicted) | [density ]
1.38±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 5 mg/mL (9.39 mM; ultrasonic and warming and heat to 60°C) | [form ]
Solid | [pka]
5.72±0.70(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Biological Activity]
DGK-IN-1 is a T cell activator extracted from patent WO2020006018A1, example 25. DGK-IN-1 can be used for tumor immunity[1]. | [References]
[1]. WO2020006018A1 |
|
| Company Name: |
Abosyn
|
| Tel: |
0512-69561983 13914027025 |
| Website: |
abosyn.cn/ |
|